Distinguish Title Data
Industry News Observation: Addressing the "High Medical Costs" Issue — More Quality Drugs Included in the Medical Insurance Reimbursement List 2022-09-09
Industry The Vaccine Hasn’t Changed: Why Has the 9-Valent HPV Vaccine Expanded Its Age Range to 9–45? 2022-09-02
Industry Zhejiang Centralized Procurement Reshapes 400 Million Yuan Market: 22 Varieties Head to the Test 2022-08-26
Industry The Essential Medicines Shortage List is Here! Including National Centralized Procurement Suppliers, All to be Included in End-Point Monitoring 2022-08-12
Industry Levetiracetam’s centralized procurement shake-up: anti-epileptic drug sparks domestic ambition to catch up and surpass 2022-08-05
Industry Direct cross-region medical settlement is here! With “nationwide coordination” of medical insurance, major local drug varieties face uncertainty, and provincial markets are in for a major reshuffle. 2022-07-29
Industry Didi's "8 Billion Yuan Fine" Serves as a Wake-Up Call for Online Pharmaceutical Services! 2022-07-22
Industry Although China started late in the global expansion of generic drugs, the future holds promising prospects. 2022-07-18
Industry China proposes banning third-party platforms from direct online drug sales. What’s the impact? 2022-07-01
Industry The National Health Commission issues the Monkeypox Diagnosis and Treatment Guidelines (2022 Edition). 2022-06-17
Industry Moving Away from Me-too R&D: China’s Innovative Drug Companies Seek Progress Amid Change 2022-06-10
Industry Domestic Innovative Drug Companies Face Setbacks in Global Expansion: How Can They Crack the Code? 2022-05-19